Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug

Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study aims at evaluating the effect of gemcitabine on single living cells using micro-Raman imaging. We used as a model the non-small lung cancer cell...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Analyst (London) Ročník 136; číslo 13; s. 2718
Hlavní autori: Draux, Florence, Gobinet, Cyril, Sulé-Suso, Josep, Manfait, Michel, Jeannesson, Pierre, Sockalingum, Ganesh D
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 07.07.2011
Predmet:
ISSN:1364-5528, 1364-5528
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study aims at evaluating the effect of gemcitabine on single living cells using micro-Raman imaging. We used as a model the non-small lung cancer cell line, Calu-1, exposed to cytostatic doses (1 nM to 1 μM for 24 h and 48 h) of gemcitabine, an antitumor drug currently used in the treatment of lung cancer. Following drug treatment as a function of doses and incubation times, the Raman maps of single living cells were acquired. Cell biomolecules (DNA, RNA, and proteins) were chemically extracted and their spectral signatures used to evaluate their respective distribution in the cellular spectral information of control and treated cells. The quantification of these distributions reveals a significant effect of 100 nM gemcitabine at 48 h incubation (concomitant decrease of nucleic acids and increase of proteins). PCA analyses performed both on nuclear and extracted biomolecules spectra show a time-dependent effect of the drug. These promising results reveal that effects of subtoxic doses can be monitored at the single cell level highlighting the importance of such studies for clinical applications.
AbstractList Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study aims at evaluating the effect of gemcitabine on single living cells using micro-Raman imaging. We used as a model the non-small lung cancer cell line, Calu-1, exposed to cytostatic doses (1 nM to 1 μM for 24 h and 48 h) of gemcitabine, an antitumor drug currently used in the treatment of lung cancer. Following drug treatment as a function of doses and incubation times, the Raman maps of single living cells were acquired. Cell biomolecules (DNA, RNA, and proteins) were chemically extracted and their spectral signatures used to evaluate their respective distribution in the cellular spectral information of control and treated cells. The quantification of these distributions reveals a significant effect of 100 nM gemcitabine at 48 h incubation (concomitant decrease of nucleic acids and increase of proteins). PCA analyses performed both on nuclear and extracted biomolecules spectra show a time-dependent effect of the drug. These promising results reveal that effects of subtoxic doses can be monitored at the single cell level highlighting the importance of such studies for clinical applications.
Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study aims at evaluating the effect of gemcitabine on single living cells using micro-Raman imaging. We used as a model the non-small lung cancer cell line, Calu-1, exposed to cytostatic doses (1 nM to 1 μM for 24 h and 48 h) of gemcitabine, an antitumor drug currently used in the treatment of lung cancer. Following drug treatment as a function of doses and incubation times, the Raman maps of single living cells were acquired. Cell biomolecules (DNA, RNA, and proteins) were chemically extracted and their spectral signatures used to evaluate their respective distribution in the cellular spectral information of control and treated cells. The quantification of these distributions reveals a significant effect of 100 nM gemcitabine at 48 h incubation (concomitant decrease of nucleic acids and increase of proteins). PCA analyses performed both on nuclear and extracted biomolecules spectra show a time-dependent effect of the drug. These promising results reveal that effects of subtoxic doses can be monitored at the single cell level highlighting the importance of such studies for clinical applications.Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study aims at evaluating the effect of gemcitabine on single living cells using micro-Raman imaging. We used as a model the non-small lung cancer cell line, Calu-1, exposed to cytostatic doses (1 nM to 1 μM for 24 h and 48 h) of gemcitabine, an antitumor drug currently used in the treatment of lung cancer. Following drug treatment as a function of doses and incubation times, the Raman maps of single living cells were acquired. Cell biomolecules (DNA, RNA, and proteins) were chemically extracted and their spectral signatures used to evaluate their respective distribution in the cellular spectral information of control and treated cells. The quantification of these distributions reveals a significant effect of 100 nM gemcitabine at 48 h incubation (concomitant decrease of nucleic acids and increase of proteins). PCA analyses performed both on nuclear and extracted biomolecules spectra show a time-dependent effect of the drug. These promising results reveal that effects of subtoxic doses can be monitored at the single cell level highlighting the importance of such studies for clinical applications.
Author Sulé-Suso, Josep
Manfait, Michel
Draux, Florence
Jeannesson, Pierre
Gobinet, Cyril
Sockalingum, Ganesh D
Author_xml – sequence: 1
  givenname: Florence
  surname: Draux
  fullname: Draux, Florence
  organization: Equipe MéDIAN, Université de Reims Champagne-Ardenne, CNRS UMR-MEDyC, UFR de Pharmacie, IFR, France
– sequence: 2
  givenname: Cyril
  surname: Gobinet
  fullname: Gobinet, Cyril
– sequence: 3
  givenname: Josep
  surname: Sulé-Suso
  fullname: Sulé-Suso, Josep
– sequence: 4
  givenname: Michel
  surname: Manfait
  fullname: Manfait, Michel
– sequence: 5
  givenname: Pierre
  surname: Jeannesson
  fullname: Jeannesson, Pierre
– sequence: 6
  givenname: Ganesh D
  surname: Sockalingum
  fullname: Sockalingum, Ganesh D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21562654$$D View this record in MEDLINE/PubMed
BookMark eNpNUMtKxEAQHGTFfejFD5C5eYrOI5lMvMniCxYE0XPo6XSWSDJZM4m4f2-iK3iq7qIoqmrJZr71xNi5FFdS6OwaBXghsszCEVtIbeIoSZSd_bvnbBnCuxBCikScsLmSiVEmiRcMX6ABz6sGtpXf8rbkYcSaeF19TgRSXYcbvutaN71UloR9mHRjiAj3fdu3XxXyog30Q49m4PsqQvBIHS-6YXvKjkuoA50dcMXe7u9e14_R5vnhaX27iVDHto9SsgbASdCoRYxGa2vIxUanaDDNrCuF0gRUiCLJCNA5ixoJy0KTAiXUil3--o5pPwYKfd5UYSoAntoh5DZVUtlUylF5cVAOrqEi33XjAN0-_9tFfQOb92ds
CitedBy_id crossref_primary_10_1002_cphc_201200800
crossref_primary_10_1039_C4AN00250D
crossref_primary_10_1039_C7AN01287J
crossref_primary_10_1007_s10719_016_9743_6
crossref_primary_10_1080_03602532_2017_1302465
crossref_primary_10_1140_epjti_s40485_015_0016_8
crossref_primary_10_1038_srep33045
crossref_primary_10_1039_c2an35170f
crossref_primary_10_3390_jpm12101644
crossref_primary_10_1186_s40580_018_0143_4
crossref_primary_10_1002_jbio_201700258
crossref_primary_10_1039_c3an00968h
crossref_primary_10_1002_anie_201607604
crossref_primary_10_1371_journal_pone_0079761
crossref_primary_10_1039_c2ay25951f
crossref_primary_10_1038_s41598_019_48895_7
crossref_primary_10_1515_psr_2017_0047
crossref_primary_10_1366_12_06971
crossref_primary_10_1039_D0SC02221G
crossref_primary_10_1002_cyto_a_22488
crossref_primary_10_1111_srt_12228
crossref_primary_10_1039_C3AN01381B
crossref_primary_10_1007_s00216_013_7143_3
crossref_primary_10_1039_C6AN02469F
crossref_primary_10_1002_ange_201607604
crossref_primary_10_1016_j_jphotobiol_2021_112366
crossref_primary_10_1517_17460441_2015_981522
crossref_primary_10_1002_jbio_201600015
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1039/c0an00998a
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Chemistry
EISSN 1364-5528
ExternalDocumentID 21562654
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.HR
0-7
0R~
23M
2WC
4.4
5RE
705
70~
7~J
AAEMU
AAIWI
AAJAE
AANOJ
AAWGC
AAXHV
AAXPP
ABASK
ABDVN
ABEMK
ABJNI
ABOCM
ABPDG
ABRYZ
ABXOH
ACGFS
ACIWK
ACLDK
ADMRA
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRZK
AFVBQ
AGEGJ
AGRSR
AHGCF
AIDUJ
AKMSF
ALMA_UNASSIGNED_HOLDINGS
ANBJS
ANUXI
APEMP
ASKNT
AUDPV
AZFZN
BLAPV
BSQNT
C6K
CAG
CGR
COF
CS3
CUY
CVF
EBS
ECGLT
ECM
EE0
EF-
EIF
EJD
F5P
GGIMP
GNO
H13
HZ~
H~N
IDZ
J3G
J3H
J3I
M4U
N9A
NPM
O9-
P2P
R56
R7B
R7E
RAOCF
RCNCU
ROL
RPMJG
RRA
RRC
RSCEA
SC5
SKM
SKR
SKZ
SLC
SLF
TN5
UPT
VH6
WH7
~02
7X8
AAFBY
AGMRB
ID FETCH-LOGICAL-c348t-7e86aab1a3c304c63386eb4637c6c798bf023eaed0d59eacbb8c3cecfd3e2a202
IEDL.DBID 7X8
ISICitedReferencesCount 35
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000291611800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1364-5528
IngestDate Sun Nov 09 09:49:35 EST 2025
Mon Jul 21 05:54:56 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 13
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c348t-7e86aab1a3c304c63386eb4637c6c798bf023eaed0d59eacbb8c3cecfd3e2a202
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21562654
PQID 872128711
PQPubID 23479
ParticipantIDs proquest_miscellaneous_872128711
pubmed_primary_21562654
PublicationCentury 2000
PublicationDate 2011-07-07
PublicationDateYYYYMMDD 2011-07-07
PublicationDate_xml – month: 07
  year: 2011
  text: 2011-07-07
  day: 07
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Analyst (London)
PublicationTitleAlternate Analyst
PublicationYear 2011
SSID ssj0001050
Score 2.1701229
Snippet Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 2718
SubjectTerms Antineoplastic Agents - pharmacology
Antineoplastic Agents - toxicity
Cell Line, Tumor
Cell Proliferation - drug effects
Cell Survival
Deoxycytidine - analogs & derivatives
Deoxycytidine - pharmacology
Deoxycytidine - toxicity
DNA - metabolism
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor - methods
Humans
Intracellular Space - drug effects
Intracellular Space - metabolism
Molecular Imaging - methods
Principal Component Analysis
Proteins - metabolism
Quartz
RNA - metabolism
Single-Cell Analysis - methods
Spectrum Analysis, Raman
Title Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug
URI https://www.ncbi.nlm.nih.gov/pubmed/21562654
https://www.proquest.com/docview/872128711
Volume 136
WOSCitedRecordID wos000291611800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qBL34_TG_yMFrWNekSepFRBwedAxR2G0kL4kUtnaum-h_b9J2ehIPXgotbcnHy8vv_fr6fghdSuG4pioiMpGGsDRKiYy1JJHramadEQ6qOrMPot-Xw2E6aHJzyiatcukTK0dtCggceUf6UCWg--719I0E0ajwcbVR0FhFLeqRTFiXYvhTLNxDh_onYc5IksRyWZ2Uph2IVB7AkVS_I8tqh-lt_7NtO2irgZb4praFXbRi8z20cbtUdNtH8KQmKsfZpFImwoXDgSgYWzzOAq2AA4lfXuGgMRNOm1SPcF9e5AQ-58W8-MgAm6K01WX_Mj8xGYFgOjNsZovXA_TSu3u-vSeNyAIByuScCCu5UrqrKNCIAfchK7eacSqAg0ildn5Xt8qayCSp99JaS6BgwRlqYxVH8SFa842wxwgzziOrPGbQLGXCKWWTBEAo8LugsV1oI7wcvpHveeiUym2xKEffA9hGR_UUjKZ1sY2RhyQ-5krYyd8Pn6LNmvEN5OsZajm_gO05Wof3eVbOLirj8Mf-4PELnzHG6Q
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Raman+imaging+of+single+living+cells%3A+probing+effects+of+non-cytotoxic+doses+of+an+anti-cancer+drug&rft.jtitle=Analyst+%28London%29&rft.au=Draux%2C+Florence&rft.au=Gobinet%2C+Cyril&rft.au=Sul%C3%A9-Suso%2C+Josep&rft.au=Manfait%2C+Michel&rft.date=2011-07-07&rft.eissn=1364-5528&rft.volume=136&rft.issue=13&rft.spage=2718&rft_id=info:doi/10.1039%2Fc0an00998a&rft_id=info%3Apmid%2F21562654&rft_id=info%3Apmid%2F21562654&rft.externalDocID=21562654
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-5528&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-5528&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-5528&client=summon